clindamycin has been researched along with Candida Infection in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Dhanasekaran, S; Manoharan, SS; Selvadoss, PP | 1 |
| Kadri, SS | 1 |
| Kumamoto, CA; Lee, K; Markey, L; Pugliese, A; Roy, F; Tian, T | 1 |
| Kim, YG; Núñez, G; Shibuya, A; Totsuka, N; Udayanga, KG; Weinberg, JB | 1 |
| Block, SL | 1 |
| Ben-Ami, R; Bishara, J; Block, C; Chazan, B; Chowers, M; Dan, M; Giladi, M; Kassis, I; Keller, N; Kontoyiannis, DP; Krieger, M; Olshtain-Pops, K; Oren, I; Potasman, I; Shalit, I; Weber, G; Weinberger, M; Wiener-Well, Y; Zimhony, O | 1 |
| Kotsuji, F; Nishijima, K; Shukunami, K | 1 |
| Garibay, M; Godínez, V; Mirabent, F; Pérez Calderón, A | 1 |
| Pohjola-Sintonen, S; Ruutu, P; Tallroth, K | 1 |
| Adams, RB; May, AK; Pruett, TL; Rosenlof, LK; Sawyer, RG | 1 |
| Christensson, B | 1 |
| Stern, GA | 1 |
| Beecroft, WA; Cogan, AG; Stoykewych, AA | 1 |
| Kitz, DJ; Little, JR; Neuman, HR | 1 |
| Ekenna, O; Sherertz, RJ | 1 |
| Graham, WP; Whitaker, LA | 1 |
1 trial(s) available for clindamycin and Candida Infection
| Article | Year |
|---|---|
[Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clindamycin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ketoconazole; Middle Aged; Vaginitis; Vaginosis, Bacterial | 2005 |
15 other study(ies) available for clindamycin and Candida Infection
| Article | Year |
|---|---|
Anti-Fungal Potential of Structurally Diverse FDA-Approved Therapeutics Targeting Secreted Aspartyl Proteinase (SAP) of Candida albicans: an In Silico Drug Repurposing Approach.
Topics: Anti-Bacterial Agents; Aspartic Acid Endopeptidases; Aspartic Acid Proteases; Aztreonam; Candida albicans; Candidiasis; Clindamycin; Drug Repositioning; Humans; Meropenem; Metronidazole | 2023 |
Key Takeaways From the U.S. CDC's 2019 Antibiotic Resistance Threats Report for Frontline Providers.
Topics: Acinetobacter Infections; Candida; Candidiasis; Centers for Disease Control and Prevention, U.S.; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Fungal; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Pseudomonas Infections; Streptococcal Infections; United States; Vancomycin Resistance | 2020 |
Decreased Ecological Resistance of the Gut Microbiota in Response to Clindamycin Challenge in Mice Colonized with the Fungus Candida albicans.
Topics: Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cecum; Clindamycin; Disease Models, Animal; Feces; Female; Gastrointestinal Microbiome; Genetic Variation; Mice; Mice, Inbred C57BL | 2021 |
Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.
Topics: Adoptive Transfer; Ampicillin; Animals; Anti-Bacterial Agents; Aspirin; Candida; Candidiasis; Cefoperazone; Celecoxib; Clindamycin; Cyclooxygenase Inhibitors; Dinoprostone; Dysbiosis; Feces; Gastrointestinal Tract; Inflammation; Lung; Macrophage Activation; Macrophages, Alveolar; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyrazoles; Sulfonamides | 2014 |
Tricky triggers of intertrigo.
Topics: Acyclovir; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antiviral Agents; Candidiasis; Child, Preschool; Clindamycin; Female; Herpes Simplex; Humans; Infant; Infant, Newborn; Intertrigo; Ketoconazole; Male; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim | 2014 |
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida glabrata; Candidemia; Candidiasis; Carbapenems; Clindamycin; Coinfection; Colistin; Drug Resistance, Fungal; Female; Fluconazole; Humans; Israel; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Prospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin.
Topics: Anti-Bacterial Agents; Candidiasis; Clindamycin; Disease Progression; Female; Gestational Age; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Sepsis; Vaginosis, Bacterial | 2004 |
Hematogenous Candida spondylitis. A case report.
Topics: Amphotericin B; Candidiasis; Clindamycin; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Lumbar Vertebrae; Middle Aged; Osteomyelitis; Spondylitis | 1984 |
The role of Candida albicans in the pathogenesis of experimental fungal/bacterial peritonitis and abscess formation.
Topics: Abscess; Amphotericin B; Animals; Bacteroides fragilis; Bacteroides Infections; Candida albicans; Candidiasis; Cefotetan; Cefoxitin; Clindamycin; Colony Count, Microbial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred BALB C; Peritoneal Diseases; Peritonitis; Survival Rate | 1995 |
Erroneous statistical evaluation of a new diagnostic test for invasive Candida infection.
Topics: Antigens, Fungal; Artifacts; Candidiasis; Clindamycin; Evaluation Studies as Topic; Humans; Leukopenia; Neoplasms; Predictive Value of Tests; Prevalence | 1995 |
In vitro antibiotic synergism against ocular fungal isolates.
Topics: Amphotericin B; Anti-Bacterial Agents; Candidiasis; Clindamycin; Drug Synergism; Eye; Fungi; Fusarium; Gentamicins; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Natamycin; Rifampin; Tetracyclines | 1978 |
Fatal necrotizing fasciitis of dental origin.
Topics: Adult; Bacteroides Infections; Candidiasis; Cefotaxime; Clindamycin; Cloxacillin; Fasciitis; Female; Focal Infection, Dental; Gentamicins; Humans; Metronidazole; Multiple Organ Failure; Neck Muscles; Necrosis; Penicillin G; Periapical Abscess; Shock, Septic; Staphylococcal Infections; Streptococcal Infections; Superinfection | 1992 |
Clindamycin enhances murine delayed-type hypersensitivity and anti-candidal activity.
Topics: Animals; Candida; Candidiasis; Clindamycin; Female; Hypersensitivity, Delayed; Kidney; Liver; Macrophages; Mice; Mice, Inbred Strains; Phagocytosis; Spleen; Time Factors | 1989 |
Factors affecting colonization and dissemination of Candida albicans from the gastrointestinal tract of mice.
Topics: Animals; Anti-Bacterial Agents; Candidiasis; Cecum; Clindamycin; Coprophagia; Cyclophosphamide; Digestive System; Gentamicins; Immunosuppression Therapy; Methotrexate; Mice; Steroids; Tissue Distribution | 1987 |
Management of hand infections in the narcotic addict.
Topics: Adult; Bacterial Infections; Candida; Candidiasis; Clindamycin; Hand; Hand Injuries; Heroin Dependence; Humans; Infections; Injections; Length of Stay; Lincomycin; Penicillins; Skin Transplantation; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Substance-Related Disorders; Surgery, Plastic; Transplantation, Autologous; Transplantation, Homologous | 1973 |